An allegory that captures today’s health technology impasse is the legend of the Gordian knot. Alexander the Great faced the challenge of untying an intricate knot so entangled it was impossible to ...
ConcertAI ® , the real‑world healthcare intelligence company for those advancing research, treatment, and care in oncology and other complex diseases, is unveiling enhancements to its CancerLinQ® ...
Please provide your email address to receive an email when new articles are posted on . ASCO today announced the partnership between its wholly owned subsidiary CancerLinQ and the software company SAP ...
CancerLinQ is a big data platform developed by the American Society of Clinical Oncology (ASCO) that aggregates clinical data from electronic health records for quality benchmarking and hypothesis ...
Mobile Applications: Breaking Barriers to Early Breast and Cervical Cancer Detection in Underserved Communities To attempt to identify transgender people with cancer within CancerLinQ, we used three ...
A major technical partner is announced for the long-awaited HIT initiative that will give oncologists a data-derived "second opinion" right from their desktops, with the earliest versions scheduled to ...
The CancerLinQ big-data system, designed by the American Society of Clinical Oncology (ASCO), was discussed and demonstrated June 1 during the organization’s annual meeting for oncology professionals ...
CancerLinQ SmartLinQ™ solutions save time, enabling practitioners to focus on providing care with seamless participation in ASCO’s flagship quality program, ASCO Certified™ CAMBRIDGE, Mass., August 27 ...
ALEXANDRIA, Va., February 22, 2017 - CancerLinQ LLC and the American Society for Radiation Oncology (ASTRO) are partnering to bring radiation oncology expertise to CancerLinQ and improve the care of ...
CancerLinQ, an HIT platform that works to improve the understanding and treatment of cancer, has completed agreements with 36 oncology practices across the nation. CancerLinQ is a subsidiary of the ...
Please provide your email address to receive an email when new articles are posted on . CHICAGO — ASCO’s big-data initiative CancerLinQ announced a long-term partnership with the FDA to use patient ...
New role: Effective Aug. 3, he will become CEO of CancerLinQ, a not-for-profit subsidiary of the American Society of Clinical Oncology. CancerLinQ is a big data initiative launched in April. More than ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results